1. Unlike Pfizer and Moderna, the COVID-19 vaccine developed by Novavax isn’t mRNA-based. Instead, it contains a COVID-19 spike protein.
2. Novavax can be stored at a warmer — but still cold — temperature than Pfizer and Moderna’s vaccines.
3. The manufacturing process involves “turning cells into protein-producing factories, which then requires processing and purification.”
